It’s shown impressive results in clinical trials to treat leukemia
A new drug called Venetoclax seems promising; in first phase of a clinical trial, nearly 80 percent of patients responded to the drug, and 20 percent were into complete…
It’s shown impressive results in clinical trials to treat leukemia